Endoscopy services are central to the NHS diagnostic pathway. Procedures such as gastroscopy, colonoscopy and flexible ...

A new NHS-first, AI-enabled case-finding pathway has launched across North East Essex, aiming to improve the early detection ...

GXO will manage the provision of national bowel cancer home testing kits for NHS EnglandLONDON, U.K., March 30, 2026 (GLOBE NEWSWIRE) -- GXO ...

The MarketWatch News Department was not involved in the creation of this content. OXFORD, United Kingdom and HOUSTON, Jan. 29, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer risk ...

A new NHS-first, AI-enabled case-finding pathway has launched across North East Essex, aiming to improve the early detection of Oesophageal and stomach cancers, some of the hardest cancers to diagnose ...

IW Capital has invested in Lucida Medical, a Cambridge and UK healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately.

GXO is ramping up its drive into the healthcare logistics sector after landing a contract to manage NHS England's bowel cancer home testing programme across England.

Only half of people with cancer are diagnosed on time following urgent NHS referral, and for some cancers this drops to less than a third, analysis shows. The NHS target for England is to rule cancer ...